A randomised, prospective, double-blind, propiverine-controlled trial to study efficacy and safety of imidafenacin in patients with overactive bladder.
Phase of Trial: Phase IV
Latest Information Update: 06 Nov 2015
At a glance
- Drugs Imidafenacin (Primary) ; Propiverine
- Indications Overactive bladder
- Focus Therapeutic Use
- 06 Nov 2015 New trial record